Veracyte Inc (NASDAQ:VCYT)

52.58
Delayed Data
As of Apr 09
 -0.79 / -1.48%
Today’s Change
21.19
Today|||52-Week Range
86.03
+7.44%
Year-to-Date
3 Cancer Diagnostic Monster Stocks on Sale
Apr 03 / MotleyFool.com - Paid Partner Content
Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath
Apr 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close53.37
Today’s open50.92
Day’s range50.92 - 54.05
Volume43,129
Average volume (3 months)966,253
Market cap$3.5B
Data as of 4:00pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)-140.10%
Earnings growth (this year)+54.62%
Earnings growth (next 5 years)--
Revenue growth (last year)-2.40%
P/E ratioNM
Price/Sales22.18
Price/Book7.22

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc-1.09-1.50%
----
--Quidel Corp+0.50+0.46%
MYGNMyriad Genetics Inc-0.32-1.12%
Data as of 4:00pm ET, 04/09/2021

Financials

Next reporting dateMay 4, 2021
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$117.5M
Annual profit (last year)-$34.9M
Net profit margin-29.71%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts